A proportion of 5-10% breast cancer resulted from hereditary germline pathogenic variants (GPVs) in cancer predisposition genes (CPGs) such as BRCA1/2, PALB2, etc. (3–5) The BRCA-related breast cancer has demonstrated distinct clinical phenotypes in pathology features and imaging manifestations (6). The gene discussed is PALB2; the disease is breast cancer.